“Marc has great experience in the space and his work product is excellent.”
— Chambers USA 2024
Marc Wagner focuses his practice on regulatory and transactional matters, primarily in the healthcare and life sciences industries. He advises companies and executives on Food and Drug Administration (FDA), Drug Enforcement Administration (DEA) and state board of pharmacy compliance and enforcement. Clients in the drug supply chain seek his strategic guidance on critical diligence, regulatory and litigation matters.
